This compound is a pharmaceutical intermediate featuring an amide-linked glycine residue and a benzyl side chain. It is characterized by a sulfonate ester group and an aromatic ring, with a molecular weight of approximately 315 Da and moderate polarity.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 1852472-89-9
(R)-Ethyl 2-(2-benzyl-3-((methylsulfonyl)oxy)propanamido)acetate
pharmaceutical impurity reference standard
(S)-Ethyl 2-(2-benzyl-3-((methylsulfonyl)oxy)propanamido)acetate
pharmaceutical intermediate
Methyl 2-((2R,4aS,6S,7R,8S,8aS)-7,8-bis((tert-butyldimethylsilyl)oxy)-6-((S,E)-1-((tert-butyldimethylsilyl)oxy)-3-(trimethylsilyl)allyl)octahydropyrano[3,2-b]pyran-2-yl)acetate
pharmaceutical intermediate for eribulin
Magnesium bromide 4-methoxy-3,5-dimethylbenzen-1-ide (1/1/1)
Grignard reagent for organic synthesis
Agomelatine Dimer Urea
pharmaceutical impurity reference standard
O-Desmethyl Tramadol Hydrochloride
Impurity standard for tramadol hydrochloride
2-[[(2S)-2-benzyl-3-methylsulfonyloxypropanoyl]amino]acetic acid
FREXHGIWGSQYED-NSHDSACASA-N
CS(=O)(=O)OC[C@H](CC1=CC=CC=C1)C(=O)NCC(=O)O
—